Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis.

Visceral leishmaniasis (VL) is one of the most important parasitic diseases with approximately 350 million people at risk. Due to the non availability of an ideal drug, development of a safe, effective, and affordable vaccine could be a solution for control and prevention of this disease. In this st...

Full description

Bibliographic Details
Main Authors: Pramod K Kushawaha, Reema Gupta, Chandra Dev Pati Tripathi, Prashant Khare, Anil Kumar Jaiswal, Shyam Sundar, Anuradha Dube
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049855/pdf/?tool=EBI